课题基金 / 基金详情

Intestinal Microbiome Fructan Metabolism and Symptom Generation in Childhood IBS

Intestinal Microbiome Fructan Metabolism and Symptom Generation in Childhood IBS
儿童 IBS 的肠道微生物组果聚糖代谢和症状产生
批准号:
8679136
负责人:
Bruno Pedro Chumpitazi
金额:
$17.18万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-07 至 2019-03-31
关键词:
Abdominal PainAcetic AcidsAddressAdultAffectAllyAmericanApplications GrantsAreaBacteriaBacteroidesBiochemical PathwayBioinformaticsBiological MarkersChildChildhoodClinical ResearchColonComputational BiologyDataDevelopment PlansDiagnostic testsDietDietary CarbohydratesDietary ComponentDigestive System DisordersDiseaseDouble-Blind MethodEconomicsElementsEmotionalEnvironmentEtiologyExcisionFecesFermentationFoodFosteringFoundationsFructansFructoseFunctional Gastrointestinal DisordersFundingGastroenterologistGenerationsGlucoseGoalsHealthHealth Care CostsImpairmentIngestionInstitutionIntestinesIrritable Bowel SyndromeKnowledgeLactoseLeadLearningMedical centerMedicineMentorshipMetabolicMetabolic PathwayMetabolismMetagenomicsMethodsMicrobiologyOralOrganismPainPathway interactionsPatientsPhysiciansPilot ProjectsPlacebo ControlPlacebosPlayProductionPublicationsQuality of lifeRandomizedResearchResearch MethodologyResearch PersonnelResearch Project GrantsResearch ProposalsResearch TrainingResourcesRoleSchool-Age PopulationSchoolsScientistSequence AnalysisSeveritiesStagingStatistical ModelsSucroseSymptomsTaxonTexasTherapeutic InterventionTrainingTranslatingTriad Acrylic ResinUnited StatesUnited States National Institutes of HealthWorkbasecareercareer developmentcollegedesigneffective interventioneffective therapygastrointestinalgastrointestinal symptomgut microbiotaimprovedinsightmetabolomicsmicrobialmicrobial communitymicrobiomenon-compliancenovelopen labelpatient oriented researchplanetary Atmospherepreventprofessorpublic health relevanceresearch and developmentskillssocial

项目摘要

项目成果

Bruno Pedro Chumpitazi的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 博士Chumpitazi是一个委员会认证的儿科胃肠病学家和终身助理教授贝勒 医学院(NST)在临床研究方法方面具有很强的背景, 致力于将这些技能应用于肠易激综合征(IBS)的研究。他的长期职业目标是 成为一名独立的NIH资助的医生科学家,精通以患者为导向的研究, 儿童IBS的潜在病理生物学,并开发新的和易于应用的疗法。他的重点是 了解饮食和肠道微生物组之间的相互作用,这些微生物组在儿童期引起胃肠道症状 IBS.当前K23提案的目标是获得获取、分析和转换数据方面的培训 从与肠道微生物群相关的宏基因组学和代谢组学研究中, 目标.他的短期目标是:1)获得饮食微生物群研究的专业知识 相互作用的学习方法,用于确定微生物群落组成,微生物生化 途径潜力和微生物代谢物表征; 2)建立独立研究领域 通过生成临界质量的数据和出版物来支持成功的R 01 NIH拨款申请。 博士Chumpitazi的研究计划的目标是了解肠道微生物组在饮食中的作用, 通过进行随机、双盲、安慰剂对照饮食试验, 果聚糖挑战。他的假设是,肠易激综合征儿童摄入果聚糖后产生胃肠道症状, 与肠道微生物群落组成、果聚糖代谢潜力和发酵产物有关 由果聚糖代谢引起。在目标1中,将表征和比较微生物群落组成 果聚糖敏感(Fsens)和果聚糖不敏感(Fins)儿童之间的差异。目标2:微生物宏基因组 将在Fsens和Fins儿童之间比较与果聚糖代谢相关的特征。目标3将确定 果聚糖代谢产物与IBS症状之间的潜在关系。 这些目标通过提供IBS机械方面的培训来支持候选人的职业发展 与饮食和肠道微生物群/宏基因组/代谢组相互作用相关的病理生物学。附加密钥 候选人培训计划的要素包括:1)指导和咨询团队,其中包括 国际公认的、独立资助的研究人员,具有儿童功能性GI方面的专业知识 疾病,生物信息学,宏基因组学和代谢组学; 2)计算高级课程 生物学,微生物学,序列分析和统计建模;以及3)旨在 培养独立性。 最后,候选人的研究环境是一个卓越的学术研究机构(贝勒学院 医学)与NIH资助的(DK 58338)德克萨斯医学中心消化疾病密切相关 该中心将支持拟议的研究和职业发展计划。这种环境将 提供一个富有成效和协作的氛围,以实现研究和培训目标。与这些 充足的资源,Chumpitazi博士将完成他的职业发展计划和研究项目, 及时的方式,并为他的进展,以独立资助的医生科学家在病人 导向研究。
英文摘要
PROJECT SUMMARY Dr. Chumpitazi is a board certified pediatric gastroenterologist and tenure track Assistant Professor at Baylor College of Medicine (BCM) with a strong background in clinical research methods and an established commitment to apply these skills to the study of irritable bowel syndrome (IBS). His long term career goal is to become an independent NIH-funded physician scientist proficient in patient oriented research to elucidate the underlying pathobiology in childhood IBS and develop novel and easily applied therapies. His focus is on understanding the interactions between diet and the gut microbiome that induce GI symptoms in childhood IBS. The objective of the current K23 proposal is to obtain training in acquiring, analyzing, and translating data from metagenomic- and metabolomic-based studies related to the gut microbiota to help achieve his long term goal. His short term goals in this proposal are to: 1) Acquire expertise in the study of diet-microbiota interactions by learning methods used to determine microbial community composition, microbial biochemical pathway potential, and microbial metabolite characterization; and 2) Establish an area of independent research by generating a critical mass of data and publications to support a successful R01 NIH grant application. Dr. Chumpitazi's research proposal's objective is to understand the role of the gut microbiome in diet- induced GI symptoms in children with IBS by performing a randomized, double blind, placebo controlled dietary fructan challenge. His hypothesis is that generation of GI symptoms in children with IBS after fructan ingestion is related to gut microbial community composition, its potential for fructan metabolism, and the fermentation products resulting from fructan metabolism. In Aim 1, microbial community composition will be characterized and compared between fructan sensitive (Fsens) and fructan insensitive (Fins) children. In Aim 2, microbial metagenomic signatures related to fructan metabolism will be compared between Fsens and Fins children. Aim 3 will identify potential relationships between products of fructan metabolism and IBS symptoms. These aims support the candidate's career development by providing training in mechanistic aspects of IBS pathobiology as related to diet and gut microbiota/metagenomic/metabolomic interactions. Additional key elements of the candidate's training plan include: 1) A mentorship and advisory team, which includes internationally recognized, independently funded investigators with expertise in childhood functional GI disorders, bioinformatics, metagenomics, and metabolomics; 2) Advanced coursework in computational biology, microbiology, sequence analysis, and statistical modeling; and 3) Scholarly activities designed to foster independence. Finally, the candidate's research environment is a preeminent academic research institution (Baylor College of Medicine) closely allied with the NIH funded (DK58338) Texas Medical Center Digestive Disease Center which will support the proposed studies and career development plan. This environment will provide a productive and collaborative atmosphere to accomplish the research and training goals. With these ample resources, Dr. Chumpitazi will complete his proposed career development plan and research project in a timely manner and set the stage for his progression to an independently funded physician scientist in patient oriented research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Advancing Clinical Science in Pediatric Gastroparesis
  • 批准号:
    10319415
  • 项目类别:
  • 资助金额:
    $38.06万
  • 财政年份:
    2016
  • 负责人:
    Bruno Pedro Chumpitazi
  • 依托单位:
Advancing Clinical Science in Pediatric Gastroparesis
  • 批准号:
    10851126
  • 项目类别:
  • 资助金额:
    $31.8万
  • 财政年份:
    2016
  • 负责人:
    Bruno Pedro Chumpitazi
  • 依托单位:
Intestinal Microbiome Fructan Metabolism and Symptom Generation in Childhood IBS
  • 批准号:
    8833276
  • 项目类别:
  • 资助金额:
    $17.18万
  • 财政年份:
    2014
  • 负责人:
    Bruno Pedro Chumpitazi
  • 依托单位:
Intestinal Microbiome Fructan Metabolism and Symptom Generation in Childhood IBS
  • 批准号:
    9244023
  • 项目类别:
  • 资助金额:
    $18.15万
  • 财政年份:
    2014
  • 负责人:
    Bruno Pedro Chumpitazi
  • 依托单位:
海外基金